These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 16739353)
1. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer. Yamamoto N; Tsurutani J; Yoshimura N; Asai G; Moriyama A; Nakagawa K; Kudoh S; Takada M; Minato Y; Fukuoka M Anticancer Res; 2006; 26(1B):777-81. PubMed ID: 16739353 [TBL] [Abstract][Full Text] [Related]
2. Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer. Mori K; Kamiyama Y; Kondo T; Kano Y; Kodama T Cancer Chemother Pharmacol; 2006 Jul; 58(1):86-90. PubMed ID: 16447041 [TBL] [Abstract][Full Text] [Related]
3. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer. Akerley W; Glantz M; Choy H Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405 [TBL] [Abstract][Full Text] [Related]
4. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer. Chang AY; Boros L; Asbury R; Hui L; Rubins J Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098 [TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer. Akerley W Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123 [TBL] [Abstract][Full Text] [Related]
6. A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Fidias P; Supko JG; Martins R; Boral A; Carey R; Grossbard M; Shapiro G; Ostler P; Lucca J; Johnson BE; Skarin A; Lynch TJ Clin Cancer Res; 2001 Dec; 7(12):3942-9. PubMed ID: 11751486 [TBL] [Abstract][Full Text] [Related]
7. [Pilot study-previously treated advanced non-small cell lung cancer]. Shirahama S; Aritomi T; Takeo S; Ando K; Wakamatsu S; Kumagawa M; Ichinose I; Tamura K Gan To Kagaku Ryoho; 2004 Dec; 31(13):2133-7. PubMed ID: 15628758 [TBL] [Abstract][Full Text] [Related]
8. Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel. Juan O; Albert A; Campos JM; Caranyana V; Muñoz J; Alberola V Acta Oncol; 2007; 46(3):367-73. PubMed ID: 17450473 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study. Kahl BS; Bailey HH; Smith EP; Turman N; Smith J; Werndli J; Williams EC; Longo WL; Kim KM; McGovern J; Jumonville A Cancer Invest; 2005; 23(1):13-8. PubMed ID: 15779863 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer. Kim R; Osaki A; Toge T Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161 [TBL] [Abstract][Full Text] [Related]
11. [Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group]. Yoneda S; Nishiwaki Y; Niitani H; Kurita Y; Ariyoshi Y; Ikegami H; Furuse K; Fukuoka M; Kimura I; Hara N; Saijo N Gan To Kagaku Ryoho; 1996 May; 23(6):695-701. PubMed ID: 8645020 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer. Charoentum C; Thongprasert S; Chewasakulyong B Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374 [TBL] [Abstract][Full Text] [Related]
13. [Weekly paclitaxel therapy for metastatic breast cancer]. Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan. Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212 [TBL] [Abstract][Full Text] [Related]
15. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study. Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450 [TBL] [Abstract][Full Text] [Related]
16. Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study. Stathopoulos GP; Christodoulou Ch; Stathopoulos J; Skarlos D; Rigatos SK; Giannakakis T; Armenaki O; Antoniou D; Athanasiadis A; Giamboudakis P; Dimitroulis J; Georgatou N; Katis K Cancer Chemother Pharmacol; 2006 Jun; 57(6):796-800. PubMed ID: 16142488 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712. Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR; J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer]. Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348 [TBL] [Abstract][Full Text] [Related]
20. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group. Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]